CLINICAL_TRIALS ClinicalTrials.gov record update

Contrast The Role of Microfibrillar Collagen Hemostat Flour（Avitene） And OK-432 （Sapylin）in Reducing Seroma Formation After Axillary Lymphadenectomy for Breast Cancer

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT02158299
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:35:40.955117+00:00
Published At: 2014-06-06T00:00:00+00:00
Record Updated At: 2014-06-06
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Drainage", "Postoperative Complications"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2014-06-06"
protocolSection.identificationModule.nctId: "NCT02158299"
protocolSection.identificationModule.officialTitle: "Contrast The Role of Microfibrillar Collagen Hemostat Flour\uff08Avitene\uff09 And OK-432 \uff08Sapylin\uff09in Reducing Seroma Formation After Axillary Lymphadenectomy for Breast Cancer"
protocolSection.statusModule.overallStatus: "UNKNOWN"
protocolSection.designModule.phases: ["PHASE4"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: ""

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.